Growth Metrics

Prestige Consumer Healthcare (PBH) Cash from Financing Activities (2016 - 2025)

Prestige Consumer Healthcare has reported Cash from Financing Activities over the past 16 years, most recently at -$6.7 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$6.7 million for Q4 2025, up 87.5% from a year ago — trailing twelve months through Dec 2025 was -$129.5 million (up 45.84% YoY), and the annual figure for FY2025 was -$182.1 million, up 24.45%.
  • Cash from Financing Activities for Q4 2025 was -$6.7 million at Prestige Consumer Healthcare, up from -$74.9 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PBH hit a ceiling of $63.6 million in Q2 2021 and a floor of -$83.7 million in Q1 2021.
  • Median Cash from Financing Activities over the past 5 years was -$53.7 million (2023), compared with a mean of -$40.9 million.
  • Peak annual rise in Cash from Financing Activities hit 167.11% in 2021, while the deepest fall reached 647.88% in 2021.
  • Prestige Consumer Healthcare's Cash from Financing Activities stood at -$67.6 million in 2021, then skyrocketed by 85.18% to -$10.0 million in 2022, then crashed by 547.07% to -$64.8 million in 2023, then grew by 16.93% to -$53.9 million in 2024, then surged by 87.5% to -$6.7 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$6.7 million (Q4 2025), -$74.9 million (Q3 2025), and -$36.3 million (Q2 2025) per Business Quant data.